Department of Biotechnology, Alagappa University, Science Campus, Karaikudi 630 003, Tamil Nadu, India.
Department of Biotechnology, Alagappa University, Science Campus, Karaikudi 630 003, Tamil Nadu, India.
Int J Biol Macromol. 2020 Dec 15;165(Pt A):1175-1186. doi: 10.1016/j.ijbiomac.2020.09.233. Epub 2020 Sep 29.
In the present study, the multi-targeting antivirulence activity of tannic acid (TA) was explored against Proteus mirabilis through MS-based proteomic approach. The in vitro biofilm biomass quantification assay and microscopic analysis demonstrated the antibiofilm activity of TA against P. mirabilis in which, minimum biofilm inhibitory concentration (MBIC) of TA was found to be 200 μg/mL concentration. Moreover, the nanoscale liquid chromatography coupled to tandem mass spectrometry (nano LC-MS/MS) analysis revealed that TA (at MBIC) differentially regulated the proteins involved in fimbrial adhesion, flagellar motility, iron acquisition, Fe-S cluster assembly, heat shock response, virulence enzymes, and toxin secretion. Further, the transcriptomic analysis validated the outcomes of proteomic analysis in which, the expression level of virulence genes responsible for MR/P fimbrial adhesion (mrpA), flagellar transcriptional activation (flhD), biosynthesis of urease (ureR), hemolysin (hpmA), non-ribosomal peptide siderophore system (Nrp), oxidative stress responsible enzymes and fitness factors proteins were down-regulated in TA exposed P. mirabilis. These observations were also in correspondence with the in vitro bioassays. Thus, this study reports the feasibility of TA to act as a promising therapeutic agent against multifactorial P. mirabilis infections.
在本研究中,通过基于 MS 的蛋白质组学方法探索了单宁酸(TA)对奇异变形杆菌的多靶向抗病毒活性。体外生物膜生物量定量测定和显微镜分析表明 TA 对奇异变形杆菌具有抗生物膜活性,其中 TA 的最低生物膜抑制浓度(MBIC)被发现为 200μg/mL 浓度。此外,纳米液相色谱与串联质谱(nano LC-MS/MS)分析显示,TA(在 MBIC 时)差异调节了与菌毛粘附、鞭毛运动、铁摄取、Fe-S 簇组装、热休克反应、毒力酶和毒素分泌相关的蛋白质。进一步的转录组分析验证了蛋白质组分析的结果,其中负责 MR/P 菌毛粘附(mrpA)、鞭毛转录激活(flhD)、脲酶(ureR)、溶血素(hpmA)、非核糖体肽铁载体系统(Nrp)、与 TA 暴露的奇异变形杆菌中负责氧化应激的毒力基因表达水平下调。这些观察结果也与体外生物测定结果一致。因此,本研究报告了 TA 作为一种有前途的治疗多因素奇异变形杆菌感染的治疗剂的可行性。